Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11918564-B1 United States of America 05 Mar 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11903933-B2 United States of America 20 Feb 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11896585-B2 United States of America 13 Feb 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11850241-B1 United States of America 26 Dec 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11850240-B1 United States of America 26 Dec 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11844788-B1 United States of America 19 Dec 2023
Methods of treating gastrointestinal stromal tumors Grant US-11813251-B2 United States of America 14 Nov 2023
Amorphous kinase inhibitor formulations and methods of use thereof Grant US-11801237-B2 United States of America 31 Oct 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11793795-B2 United States of America 24 Oct 2023
Methods of treating gastrointestinal stromal tumors Grant US-11779572-B1 United States of America 10 Oct 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11612591-B2 United States of America 28 Mar 2023
Methods of treating gastrointestinal stromal tumors Grant US-11576904-B2 United States of America 14 Feb 2023
Amorphous kinase inhibitor formulations and methods of use thereof Grant US-11576903-B2 United States of America 14 Feb 2023
Methods of treating gastrointestinal stromal tumors Grant US-11534432-B2 United States of America 27 Dec 2022
Methods of treating gastrointestinal stromal tumors Grant US-11529336-B2 United States of America 20 Dec 2022
Methods of treating gastrointestinal stromal tumors Grant US-11426390-B2 United States of America 30 Aug 2022
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3… Grant US-11395818-B2 United States of America 26 Jul 2022
Methods of treating gastrointestinal stromal tumors Grant US-11344536-B1 United States of America 31 May 2022
Methods of treating gastrointestinal stromal tumors Grant US-11266635-B2 United States of America 08 Mar 2022
Amorphous kinase inhibitor formulations and methods of use thereof Grant US-11185535-B2 United States of America 30 Nov 2021
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment… Grant US-RE48731-E1 United States of America 14 Sep 2021
Methods of treating gastrointestinal stromal tumors Grant US-10966966-B2 United States of America 06 Apr 2021
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment… Grant US-8940756-B2 United States of America 27 Jan 2015